2Smith IC, Hers SD, Hutcheon AW,et aL Neoadjuvant chemotherapy in breast cancer:significantly enhanced response with docetaxol[J].J Clin Oneol, 2002, 20(6) : 1456-1466.
3Shimizu T. Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer [ J ]. Gan To Kagaku Ryoho, 2003,30 ( 1 ) :105-109.
4Gianni L, Munzone E, Capri G, et al. Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study [ J ]. J Clin Oncol, 1995, 13 ( 11 ) :2688-2699.
5Sledge GW, Neuberg D, Bermardo P, et al. Phase Ⅲ trim or doxorubicin, paclitaxel, and the combination on doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial(E 1193) [J]. J Clin Oncol, 2003, 21 (4) : 588-592.
6Suzuki M, Hirono M, Majima H. Cardiotoxicity due to prolonged administrition of THPL ( 2″ R-4′-0-tetrahydropyranyl-adriamycin ) [ J ]. Gan To Kagaku Ryoho, 1997,24 ( 13 ) : 1993-1999.
